Fulminant Idiopathic Intracranial Hypertension Should Be Redefined Without a Time Limited Definition

Menon, Vaishnavi; Hansen, Michael Stormly; Mollan, Susan P.

doi:10.1080/01658107.2024.2337165

Neuro-Ophthalmology

2024

DOI: 10.1080/01658107.2024.2337165

|View full text |Cite

Fulminant Idiopathic Intracranial Hypertension Should Be Redefined Without a Time Limited Definition

Vaishnavi Menon,

Michael Stormly Hansen,

Susan P. Mollan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Managing idiopathic intracranial hypertension in the eye clinic

Bonelli,

Menon,

Arnold

et al. 2024

Eye

Self Cite

View full text Add to dashboard Cite

Idiopathic intracranial hypertension (IIH) is a neuro-ophthalmological condition characterised by a raised intracranial pressure and papilloedema that causes disabling headaches. The main risk factors of female sex and living with obesity have been known for some time, however the knowledge of the underlying pathophysiology is evolving. Papilloedema can impact the visual function, and the majority of people are offered acetazolamide. Those with sight threatening disease need urgent management, though there is little high quality evidence to recommend any particular surgical intervention. Headache treatment is an unmet clinical need and simple medication overuse advice has the potential to reduce the chronification of migraine-like headaches. IIH is emerging as a systemic metabolic disease distinct from people living with obesity alone. While weight loss is the main stay of disease modifying therapy this is challenging to access and many healthcare professionals that manage the condition have no formal training or accessible pathways for weight management. The aim of this “how to do it” article is to present the latest advances in knowledge of IIH that we pragmatically included in routine clinical care for people living with the condition.

show abstract

Managing idiopathic intracranial hypertension in the eye clinic

Bonelli,

Menon,

Arnold

et al. 2024

Eye

Self Cite

View full text Add to dashboard Cite

show abstract

Risk factors and disease associations in people living with idiopathic intracranial hypertension

Potter,

Menon,

Mollan

2024

Expert Review of Neurotherapeutics

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Fulminant Idiopathic Intracranial Hypertension Should Be Redefined Without a Time Limited Definition

Cited by 2 publications

References 13 publications

Managing idiopathic intracranial hypertension in the eye clinic

Managing idiopathic intracranial hypertension in the eye clinic

Risk factors and disease associations in people living with idiopathic intracranial hypertension

Contact Info

Product

Resources

About